Reconcile Chewable Tablets for Dogs 8mg (Fluoxetine) Pack of 30

Understanding Separation Anxiety in Dogs

Separation anxiety can manifest in various ways, often when a dog is left alone. Common signs include destructive chewing, excessive vocalisation (barking, howling), and inappropriate urination or defecation indoors. Reconcile Chewable Tablets for Dogs 8mg (Fluoxetine) Pack of 30 is designed to help alleviate these symptoms by influencing serotonin levels in the brain, improving your dog's ability to cope with being alone.

How Reconcile Works

The active ingredient, fluoxetine, is a selective serotonin re-uptake inhibitor (SSRI). By increasing the availability of serotonin, a neurotransmitter associated with mood and behaviour, Reconcile helps to calm your dog and make them more receptive to training. It's crucial to remember that Reconcile 8mg is most effective when used as part of a comprehensive behavioural modification plan, guided by a veterinary professional.

Why Choose Reconcile 8mg from Weldricks?

As a trusted UK pharmacy, Weldricks offers genuine vet prescriptions like Reconcile 8mg with the convenience of online ordering. We understand the importance of your pet's well-being and provide professional care, discreet packaging, and reliable delivery options, including free UK delivery on orders over £40. Help your dog find calm and comfort with a product backed by our commitment to accessible healthcare.

Reconcile should be administered orally at a once daily dose of 1 to 2 mg/kg bodyweight according to the dosage table below. The tablets are flavoured and most dogs will consume the tablet when offered by the owner. Reconcile tablets may be given with or without food.

Dosage Table: Reconcile Chewable Tablets for Dogs

Clinical improvement with the product is expected within 1 to 2 weeks. If no improvement is noted within 4 weeks, case management should be re-evaluated. Clinical studies have shown that a beneficial response has been demonstrated for up to 8 weeks treatment with fluoxetine.

If a dose is missed, the next scheduled dose should be administered as prescribed. At the end of treatment it is not necessary to taper or reduce doses because of the long half-life of this veterinary medicinal product.

Contraindications

• Do not use in dogs weighing less than 4 kg.
• Do not use in dogs with epilepsy or in dogs with a history of seizures.
• Do not use in case of hypersensitivity to fluoxetine or other Selective Serotonin Re-Uptake Inhibitors (SSRIs) or to any of the excipients.

Special Precautions for Use in Animals

• The safety of Reconcile Chewable Tablets for Dogs 8mg (Fluoxetine) Pack of 30 has not been established in dogs less than 6 months of age or weighing less than 4 kg.
• Though rare, seizures may occur in dogs treated with Reconcile. Treatment should be stopped if seizures occur.

Special Precautions to be Taken by the Person Administering the Veterinary Medicinal Product to Animals

• In case of accidental self-ingestion, seek medical advice immediately and show the package leaflet or the label to the physician. In humans, the most common symptoms associated with overdose include seizures, somnolence, nausea, tachycardia, and vomiting.

Adverse Reactions (Frequency and Seriousness)

To minimize the risk of adverse reactions, the recommended dose should not be exceeded.

• Very Common (more than 1 in 10 animals treated): Decreased appetite (including anorexia); lethargy (including calmness and increased sleeping).
• Common (more than 1 but less than 10 animals in 100 animals treated): Urinary tract disorders (such as bladder infections, irregular urination, discomfort in passing urine); central nervous system signs (incoordination, disorientation).
• Uncommon (more than 1 but less than 10 animals in 1,000 animals treated): Weight loss/loss of condition; dilation of the pupils of the eye.
• Rare (more than 1 but less than 10 animals in 10,000 animals treated): Panting, seizures, vomiting.

If you notice any side effects not listed in this package leaflet or think the medicine has not worked, please inform your veterinary surgeon.

Use during Pregnancy, Lactation or Lay

The safety of Reconcile Chewable Tablets for Dogs 8mg (Fluoxetine) Pack of 30 has not been established during pregnancy and lactation, thus its use is not recommended during these periods. Do not use in breeding animals.

Interaction with Other Medicinal Products and Other Forms of Interaction

• Reconcile should not be given concomitantly with veterinary medicinal products that lower the seizure threshold (e.g., phenothiazines such as acepromazine or chlorpromazine).
• Do not use in conjunction with other serotonergic agents (e.g., sertraline) and monoamine oxidase inhibitors (MAOIs) [e.g., selegiline hydrochloride (L-deprenyl), amitraz] or tricyclic amines (TCAs) (e.g., amitriptyline and clomipramine).
• A 6-week washout interval should be observed following discontinuation of therapy with Reconcile prior to the administration of any veterinary medicinal product that may adversely interact with fluoxetine or its metabolite, norfluoxetine.
• Fluoxetine should be used with caution with other veterinary medicinal products.

• Active substance: Fluoxetine 8 mg (equivalent to 9.04 mg fluoxetine hydrochloride)
• Excipients:
  • Microcrystalline cellulose
  • Sucrose (as compressible sugar)
  • Crospovidone
  • Artificial beef flavour
  • Silica, colloidal anhydrous
  • Calcium hydrogen phosphate dihydrate
  • Magnesium stearate